REBECCA STANFORD: Open Payments
NPI 1679020630 · WEST POINT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 28 payments from 9 companies in 2025. Trend: 2023 $510 · 2024 $261 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Lilly USA, LLC | 4 | $76 |
| Corcept Therapeutics | 4 | $74 |
| Exact Sciences Corporation | 3 | $53 |
| Dexcom, Inc. | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, Korlym, Ozempic, Dexcom G6 Transmitter, AIRSUPRA, Rybelsus, The Cologuard Plus Collection Kit, FARXIGA.
Industry payments across MS — which companies pay providers there.
